TB-specific Interferon-γ concentration after treatment of latent TB-infection

A. Nienhaus, J. Torres Costa, R. Silva, R. Sá, M. J. Cardoso (Porto, Portugal; Hamburg, Germany)

Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Session: Immune responses for the diagnosis of tuberculosis
Session type: E-Communication Session
Number: 284
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Nienhaus, J. Torres Costa, R. Silva, R. Sá, M. J. Cardoso (Porto, Portugal; Hamburg, Germany). TB-specific Interferon-γ concentration after treatment of latent TB-infection. Eur Respir J 2010; 36: Suppl. 54, 284

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007



Latent TB screening before anti-TNFα treatment
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010


IFN-γ response on T-cell based assays for the diagnosis of tuberculosis infection in rheumatic patients undergoing anti-TNF-α treatment
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015



Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population
Source: Eur Respir J 2005; 26: Suppl. 49, 624s
Year: 2005

Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018


What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009


Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018



The significance of the antigen-specific IFN-γ release assay in vitro for differential diagnosis between sarcoidosis and tuberculosis (TB) patients
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010

Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007



Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI)
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007



Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008



A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Outcomes of treatment of latent tuberculosis infection in children with two different regimens
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006

Is neopterin concentration predictive in latent tuberculosis infection in health workers?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008